Quanterix Corporation Operating Lease, Right-of-Use Asset, Amortization Expense
Quanterix Corporation (QTRX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $1.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-10
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $804.00K, a 178.20% increase year-over-year.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $797.00K, a 42.07% increase year-over-year.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.02M, a 95.98% increase year-over-year.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.21M, a 127.50% increase year-over-year.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for fiscal 2025 was $3.08M, a 62.76% increase from fiscal 2024.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.89M, a 6.05% decline from fiscal 2023.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for fiscal 2023 was $2.02M, a 181.82% increase from fiscal 2022.
- Quanterix Corporation operating lease, right-of-use asset, amortization expense for fiscal 2022 was $715.00K, a 43.29% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $804.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.60M 10-Q · filed 2026-08-10 | $2.62M derived: sum of 3 quarters · filed 2026-08-10 | $3.83M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $797.00K 10-Q · filed 2026-05-06 | $1.82M derived: sum of 2 quarters · filed 2026-05-06 | $3.03M derived: sum of 3 quarters · filed 2026-05-06 | $3.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.23M derived: sum of 2 quarters · filed 2026-03-02 | $2.52M derived: sum of 3 quarters · filed 2026-08-10 | $3.08M 10-K · filed 2026-03-02 |
| 2025-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.50M derived: sum of 2 quarters · filed 2026-08-10 | $2.06M 10-Q · filed 2025-11-10 | $2.58M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $289.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $850.00K 10-Q · filed 2026-08-10 | $1.37M derived: sum of 3 quarters · filed 2026-08-10 | $1.90M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $561.00K 10-Q · filed 2026-05-06 | $1.08M derived: sum of 2 quarters · filed 2026-05-06 | $1.61M derived: sum of 3 quarters · filed 2026-05-06 | $1.98M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.05M derived: sum of 2 quarters · filed 2026-03-02 | $1.42M derived: sum of 3 quarters · filed 2026-03-02 | $1.89M 10-K · filed 2026-03-02 |
| 2024-09-30 | $531.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $893.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.37M 10-Q · filed 2025-11-10 | $1.87M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $840.00K 10-Q · filed 2025-08-07 | $1.34M derived: sum of 3 quarters · filed 2026-03-02 | $1.85M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $478.00K 10-Q · filed 2025-05-12 | $975.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.49M derived: sum of 3 quarters · filed 2026-03-02 | $2.16M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $497.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02 | $1.01M derived: sum of 2 quarters · filed 2026-03-02 | $1.68M derived: sum of 3 quarters · filed 2026-03-02 | $2.02M 10-K · filed 2026-03-02 |
| 2023-09-30 | $516.00K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $1.18M derived: sum of 2 quarters · filed 2024-12-26 | $1.52M 10-K/A · filed 2024-12-26 | $1.13M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $668.00K derived: 10-K/A 6 month − 10-Q/A 3 month · filed 2024-12-26 | $1.00M 10-K/A · filed 2024-12-26 | $618.00K derived: sum of 3 quarters · filed 2025-03-17 | $792.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $334.00K 10-Q/A · filed 2024-12-26 | -$50.00K derived: sum of 2 quarters · filed 2025-03-17 | $124.00K derived: sum of 3 quarters · filed 2025-03-17 | |
| 2022-12-31 | -$384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$210.00K derived: sum of 2 quarters · filed 2025-03-17 | $715.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.10M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $925.00K 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $499.00K 10-K/A · filed 2024-12-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |